Fallopia japonica, a Natural Modulator, Can Overcome Multidrug Resistance in Cancer Cells

Evidence-based Complementary and Alternative Medicine

Volumn 2015, Issue , 2015, Pages

  Eid, Safaa Yehia ^a,b   El Readi, Mahmoud Zaki ^a,c   Ashour, Mohamed Lotfy ^d   Wink, Michael ^b  

^a UMM AL QURA UNIVERSITY   (Saudi Arabia)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Al Azhar University   (Egypt)

^d African Union Organization St Abbassia   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ARECA CATECHU EXTRACT; CASSIA TORA EXRACT; CHRYSANTHEMUM INDICUM EXTRACT; CYMBOPOGON DISTANS EXTRACT; CYNANCHUM PANICULATUM EXTRACT; CYTOCHROME P450 3A4; CYTOTOXIC AGENT; DESMODIUM STYRACIFOLIUM EXTRACT; EMODIN; GLUTATHIONE TRANSFERASE; GLYCOPROTEIN P INHIBITOR; KADSURA LONGIPEDUNCULATA EXTRACT; KETOCONAZOLE; MENTHA HAPLOCALYX EXTRACT; MULTIDRUG RESISTANCE PROTEIN; OPHIOGLOSSUM VULGATUM EXTRACT; PARIS POLYPHYLLA EXTRACT; PATRINIA SCABIOSAEFOLIA EXTRACT; PLANT EXTRACT; POLYDATIN; POLYGONUM CUSPIDATUM EXTRACT; RESVERATROL; SANGUISORBA OFFICINALIS EXTRACT; SAPOSHNIKOVIA DIVARICATA EXTRACT; TAXILLUS CHINENSIS EXTRACT; UNCLASSIFIED DRUG; VERAPAMIL; VIOLA YEZOENSIS EXTRACT;

ANTIPROLIFERATIVE ACTIVITY; APIACEAE; ARTICLE; BETEL NUT; CACO 2 CELL LINE; CANCER CELL LINE; CANCER RESISTANCE; CHRYSANTHEMUM INDICUM; CONTROLLED STUDY; CYMBOPOGON; CYMBOPOGON DISTANS; CYNANCHUM; CYNANCHUM PANICULATUM; DESMODIUM STYRACIFOLIUM; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG POTENCY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ACTIVITY; ETHNOPHARMACOLOGY; FABACEAE; FEMALE; HELA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IC50; KADSURA; KADSURA LONGIPEDUNCULATA; LIMIT OF QUANTITATION; LIQUID CHROMATOGRAPHY; LORANTHACEAE; MEDICINAL PLANT; MENTHA; MENTHA HAPLOCALYX; MULTIDRUG RESISTANCE; OPHIOGLOSSUM VULGATUM; PARIS POLYPHYLLA; PATRINIA; PATRINIA SCABIOSAEFOLIA; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; SANGUISORBA; SANGUISORBA OFFICINALIS; SAPOSHNIKOVIA DIVARICATA; SENNA TORA; TAXILLUS CHINENSIS; VIOLA; VIOLA YEZOENSIS;

EID: 84939636578     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2015/868424     Document Type: Article

References (43)

1. S. Nobili, D. Lippi, E. Witort et al., "Natural compounds for cancer treatment and prevention," Pharmacological Research, vol. 59, no. 6, pp. 365-378, 2009.
2. D. A. Dias, S. Urban, and U. Roessner, "A historical overview of natural products in drug discovery," Metabolites, vol. 2, no. 4, pp. 303-336, 2012.
3. S. M. Colegate and R. J. Molyneux, Bioactive Natural Products: Detection, Isolation, and Structural Determination, CRC Press, Boca Raton, Fla, USA, 2nd edition, 2008.
4. D. J. Newman and G. M. Cragg, "Natural products as sources of new drugs over the last 25 years," Journal of Natural Products, vol. 70, no. 3, pp. 461-477, 2007.
5. S. Wachtel-Galor and I. F. F. Benzie, "Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs," in Herbal Medicine: Biomolecular and Clinical Aspects, I. F. F. Benzie and S. Wachtel-Galor, Eds., CRC Press, Boca Raton, Fla, USA, 2011.
6. J. W.-H. Li and J. C. Vederas, "Drug discovery and natural products: end of an era or an endless frontier?" Science, vol. 325, no. 5937, pp. 161-165, 2009.
7. V. Brower, "Back to nature: extinction of medicinal plants threatens drug discovery," Journal of the National Cancer Institute, vol. 100, no. 12, pp. 838-839, 2008.
8. M. Wink, "Evolutionary advantage and molecular modes of action of multi-component mixtures used in phytomedicine," Current Drug Metabolism, vol. 9, no. 10, pp. 996-1009, 2008.
9. J. Boik, Natural Compounds in CancerTherapy, OregonMedical Press, Princeton, Minn, USA, 2001.
10. V. S. Velingkar and V. D. Dandekar, "Modulation of Pglycoprotein mediated multidrug resistance (MDR) in cancer using chemosensitizers," International Journal of Pharmaceutical Sciences and Research, vol. 2, pp. 104-111, 2010.
11. A. Pluen, Y. Boucher, S. Ramanujan et al., "Role of tumor-host interactions in interstitial diffusion of macromolecules: cranial vs. subcutaneous tumors," Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 8, pp. 4628-4633, 2001.
12. R. K. Jain, "Delivery ofmolecular and cellularmedicine to solid tumors," Advanced Drug Delivery Reviews, vol. 46, no. 1-3, pp. 149-168, 2001.
13. Z.-P. Mao, L.-J. Zhao, S.-H. Zhou, M.-Q. Liu, W.-F. Tan, and H.-T. Yao, "Expression and significance of glucose transporter- 1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma," Oncology Letters, vol. 9, no. 2, pp. 806-810, 2015.
14. A. Cort and T. Ozben, "Natural product modulators to overcomemultidrug resistance in cancer,"Nutrition and Cancer, vol. 67, no. 3, pp. 411-423, 2015.
15. E. G. Schuetz, W. T. Beck, and J. D. Schuetz, "Modulators and substrates of P-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells," Molecular Pharmacology, vol. 49, no. 2, pp. 311-318, 1996.
16. C. Awortwe, V. K. Manda, C. Avonto et al., "Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway," Xenobiotica, vol. 45, no. 3, pp. 218-229, 2015.
17. H. Jiang, K. Chen, J. He et al., "Association of pregnane x receptor with multidrug resistance-related protein 3 and its role in human colon cancer chemoresistance," Journal of Gastrointestinal Surgery, vol. 13, no. 10, pp. 1831-1838, 2009.
18. S. R. Pondugula, P. C. Flannery, K. L. Abbott et al., "Diindolylmethane, a naturally occurring compound, induces CYP3A4 andMDR1 gene expression by activating human PXR," Toxicology Letters, vol. 232, no. 3, pp. 580-589, 2015.
19. I. G. Denisov, Y. V. Grinkova, J. L. Baylon, E. Tajkhorshid, and S. G. Sligar, "Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer," Biochemistry, vol. 54, no. 13, pp. 2227-2239, 2015.
20. F. P. Guengerich, "Cytochrome P-450 3A4: regulation and role in drug metabolism," Annual Review of Pharmacology and Toxicology, vol. 39, pp. 1-17, 1999.
21. R. C. Strange, P. W. Jones, and A. A. Fryer, "Glutathione Stransferase: genetics and role in toxicology," Toxicology Letters, vol. 112-113, pp. 357-363, 2000.
22. J. J. Doyle and J. L. Doyle, "Isolation of plant DNA from fresh tissue," Focus, vol. 12, pp. 13-15, 1990.
23. J. Carmichael, W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B. Mitchell, "Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing," Cancer Research, vol. 47, no. 4, pp. 936-942, 1987.
24. P. R. Twentyman, T. Rhodes, and S. Rayner, "A comparison of rhodamine 123 accumulation and efflux in cells with Pglycoprotein- mediated and MRP-associated multidrug resistance phenotypes," European Journal of Cancer, vol. 30, no. 9, pp. 1360-1369, 1994.
25. J. J. Cali, D. Ma, M. Sobol et al., "Luminogenic cytochrome P450 assays,"ExpertOpinion onDrugMetabolismandToxicology, vol. 2, no. 4, pp. 629-645, 2006.
26. W. H. Habig, M. J. Pabst, G. Fleischner, Z. Gatmaitan, I. M. Arias, and W. B. Jakoby, "The identity of glutathione S transferase B with ligandin, a major binding protein of liver," Proceedings of the National Academy of Sciences of the United States of America, vol. 71, no. 10, pp. 3879-3882, 1974.
27. Z. Cai, F. S. C. Lee, X. R. Wang, and W. J. Yu, "A capsule reviewof recent studies on the application ofmass spectrometry in the analysis of Chinese medicinal herbs," Journal of Mass Spectrometry, vol. 37, no. 10, pp. 1013-1024, 2002.
28. T. Yi, H. Zhang, and Z. Cai, "Analysis of rhizoma Polygoni cuspidati byHPLC and HPLC-ESI/MS," Phytochemical Analysis, vol. 18, no. 5, pp. 387-392, 2007.
29. S. Harmsen, I. Meijerman, J. H. Beijnen, and J. H.M. Schellens, "The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology," Cancer Treatment Reviews, vol. 33, no. 4, pp. 369-380, 2007.
30. M. Wink, M. L. Ashour, and M. Z. El-Readi, "Secondary metabolites from plants inhibiting ABC transporters and reversing resistance of cancer cells and microbes to cytotoxic and antimicrobial agents," Frontiers in Microbiology, vol. 3, article 130, 2012.
31. W. K. Chan and A. B. Delucchi, "Resveratrol, a red wine constituent, is a mechanism-based inactivator of cytochrome P450 3A4," Life Sciences, vol. 67, no. 25, pp. 3103-3112, 2000.
32. T. K. H. Chang, J. Chen, and W. B. K. Lee, "Differential inhibition and inactivation of human CYP1 enzymes by transresveratrol: evidence for mechanism-based inactivation of CYP1A2," Journal of Pharmacology and Experimental Therapeutics, vol. 299, no. 3, pp. 874-882, 2001.
33. M. Bhadauria, S. K. Nirala, S. Shrivastava et al., "Emodin reverses CCl4 induced hepatic cytochrome P450 (CYP) enzymatic and ultrastructural changes: the in vivo evidence," Hepatology Research, vol. 39, no. 3, pp. 290-300, 2009.
34. C.-N. Wang, Y.-J. Shiao, Y.-H. Kuo, C.-C. Chen, and Y.-L. Lin, "Inducible nitric oxide synthase inhibitors from Saposhnikovia divaricata and Panax quinquefolium," PlantaMedica, vol. 66, no. 7, pp. 644-647, 2000.
35. E. Okuyama, T. Hasegawa, T. Matsushita, H. Fujimoto, M. Ishibashi, and M. Yamazaki, "Analgesic components of Saposhnikovia root (Saposhnikovia divaricata)," Chemical & Pharmaceutical Bulletin, vol. 49, no. 2, pp. 154-160, 2001.
36. T. Kubo, S. Hamada, T. Nohara et al., "Study on the constituents of Desmodium styracifolium," Chemical and Pharmaceutical Bulletin, vol. 37, no. 8, pp. 2229-2231, 1989.
37. M. Wink and B.-E. van Wyk, Mind-Altering and Poisonous Plants of theWorld, Timber Press, Portland, Ore, USA, 2008.
38. E. E. Chang, Z.-F. Miao, W.-J. Lee et al., "Arecoline inhibits the 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced cytochrome P450 1A1 activation in human hepatoma cells," Journal of Hazardous Materials, vol. 146, no. 1-2, pp. 356-361, 2007.
39. B.-E. Van Wyk and M. Wink, Medicinal Plants of the World: An Illustrated Scientific Guide to ImportantMedicinal Plants and Their Uses, Timber Press, Portland, Ore, USA, 1st edition, 2004.
40. J.-N. Wu, An Illustrated Chinese Materia Medica, Oxford University Press, New York, NY, USA, 2005.
41. M. Zhu, P. Y. K. Wong, and R. C. Li, "Influence of Sanguisorba officinalis, a mineral-rich plant drug, on the pharmacokinetics of ciprofloxacin in the rat," Journal of Antimicrobial Chemotherapy, vol. 44, no. 1, pp. 125-128, 1999.
42. L. J. Fundukian, The Gale Encyclopedia of Alternative Medicine, Gale, Cengage Learning, Detroit, Mich, USA, 3rd edition, 2009.
43. M. Unger and A. Frank, "Simultaneous determination of the inhibitory potency of herbal extracts on the activity of sixmajor cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction," Rapid Communications in Mass Spectrometry, vol. 18, no. 19, pp. 2273-2281, 2004.